The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)

The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)

Objective: To assess the efficacy of Zafirlukast as a SARS-CoV-2 Helicase Inhibitor in adult patients with moderate COVID-19 symptoms (hospitalized patients with COVID-19 pneumonia who were not admitted to an intensive care unit). Methods: We conducted a randomized, double blind, placebo-controlled,...

Full description

Saved in:
Bibliographic Details
Main Authors: M.Al Ghobain (Author), F. Rebh (Author), A. Saad (Author), A.H. Khan (Author), N. Mehyar (Author), A. Mashhour (Author), I. Islam (Author), Y. Alobaida (Author), A.S. Alaskar (Author), M. Boudjelal (Author), M.Al Jeraisy (Author)
Format: Book
Published: Elsevier, 2022-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items